GlassScriptPhysician profile
Carla Carter
NPI 1902184369
$820.69
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $224 · 2021: $57.51 · 2022: $100 · 2023: $22.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $293.45 | 2019-2021 | |
| Allergan, INC. | $156.03 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.84 | 2019 | |
| Ivantis, INC | $72.28 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $55.86 | 2019-2022 | |
| Coopervision INC. | $35.51 | 2022 | |
| Abbvie INC. | $27.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.78 | 2021-2022 | |
| Astellas Pharma US INC | $22.21 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.